Your browser doesn't support javascript.
loading
Efficacy of antiandrogens in androgen receptor-positive triple-negative metastatic breast cancer: Real-life data.
Rhanine, Yasmine; Bonnefoi, Hervé; Goncalves, Anthony; Debled, Marc; Le Moulec, Sylvestre; Bonichon, Nathalie; Macgrogan, Gaetan; Arnedos, Monica; Dubroca-Dehez, Bénédicte; Grellety, Thomas.
Afiliación
  • Rhanine Y; Medical Oncology Department, Institut Bergonié, Bordeaux, France.
  • Bonnefoi H; Medical Oncology Department, Institut Bergonié and Université de Bordeaux, UFR Sciences Médicales, Bordeaux, France.
  • Goncalves A; Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France.
  • Debled M; Medical Oncology Department, Institut Bergonié, Bordeaux, France.
  • Le Moulec S; Medical Oncology Department, Polyclinique Marzet, Pau, France.
  • Bonichon N; Medical Oncology Department, Clinique Tivoli, Bordeaux, France.
  • Macgrogan G; Pathology Department, Institut Bergonié, Bordeaux, France.
  • Arnedos M; Medical Oncology Department, Institut Bergonié, Bordeaux, France.
  • Dubroca-Dehez B; Medical Information Department, Centre Hospitalier de la Côte Basque, Bayonne, France.
  • Grellety T; Medical Oncology Department, Centre Hospitalier de la Côte Basque, Bayonne, France. Electronic address: tgrellety@ch-cotebasque.fr.
Breast ; 73: 103667, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38160476
ABSTRACT
Antiandrogens (AA) have been tested in clinical trials in androgen receptor (AR) + triple-negative breast cancer (TNBC). We aim to assess the clinical benefit rate (CBR) of AA in real life. The primary end-point was CBR at 6 months. Twenty-four patients were assessable and received abiraterone acetate (62 %), enzalutamide (8 %) and bicalutamide (30 %). CBR at 6 months was 29 % (7/24) with 2 CR, 3 PR and 2 SD. Four patients had a clinical benefit >12 months. Real-life efficacy of AA use in metastatic AR + TNBC are in line with data from published trials.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas / Antagonistas de Andrógenos Límite: Humans Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas / Antagonistas de Andrógenos Límite: Humans Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Francia